Merck & Co., Inc. (MRK.MX)
Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
At close: 01:06PM CDT
| Previous close | 1,798.50 |
| Open | 0.00 |
| Bid | 1,765.00 x 49400 |
| Ask | 1,799.99 x 13500 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 3,443 |
| Market cap | 4.56T |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | 30.96 |
| EPS (TTM) | 58.07 |
| Earnings date | 27 Apr 2022 - 02 May 2022 |
| Forward dividend & yield | 56.53 (3.12%) |
| Ex-dividend date | 14 Sept 2022 |
| 1y target est | N/A |
- Business Wire
FDA Accepts Submission of Supplemental New Drug Application for LYNPARZA® (olaparib) in Combination With Abiraterone and Prednisone or Prednisolone for Patients With Metastatic Castration-Resistant Prostate Cancer and Grants Priority Review
RAHWAY, N.J., August 16, 2022--FDA Accepts Submission of sNDA for LYNPARZA® in Combination With Abiraterone and Prednisone for Patients With mCRPC and Grants Priority Review
- Business Wire
Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology
RAHWAY, N.J. & CAMBRIDGE, Mass., August 16, 2022--Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology
- Zacks
Illumina (ILMN) Q2 Earnings Miss Estimates, Slashes '22 View
Robust sales contribution across operating segments drove Illumina's (ILMN) Q2 top line.
© 2022 Yahoo. All rights reserved.
